Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy

PURPOSE: Gephyrin (GPHN) is an essential protein in the regulation of inhibitory postsynaptic density and polymorphism in the corresponding gene may have a role in the development of pharmacoresistant epilepsy (PRE). For the first time, we aimed to evaluate the association of rs928553T/C variants wi...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Tallawy, Hamdy N, Abuhamdah, Sawsan, Nassar, Ahmed Y, Farghaly, Wafaa M A, Saleem, Tahia H, Atta, Sara A, Sayed, Ayat A, Tohamy, Amal M, Hassan, Mohammed H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437390/
https://www.ncbi.nlm.nih.gov/pubmed/34526803
http://dx.doi.org/10.2147/PGPM.S327808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437390/
https://www.ncbi.nlm.nih.gov/pubmed/34526803
http://dx.doi.org/10.2147/PGPM.S327808

Ejemplares similares